Multicenter randomized phase II clinical trial of oxaliplatin reintroduction as a third- or later-line therapy for metastatic colorectal cancer-biweekly versus standard triweekly XELOX (The ORION Study).

Multicenter randomized phase II clinical trial of oxaliplatin reintroduction as a third- or later-line therapy for metastatic colorectal cancer-biweekly versus standard triweekly XELOX (The ORION Study).

Item

http://www.wikidata.org/entity/Q41207847

Q41207847

about

Beyond second-line therapy in patients with metastatic colorectal cancer: a systematic review.

P2860

Q49922743-A1490491-5841-49B8-8AED-B8F6B3266869

P2860

Multicenter randomized phase II clinical trial of oxaliplatin reintroduction as a third- or later-line therapy for metastatic colorectal cancer-biweekly versus standard triweekly XELOX (The ORION Study).

Item

http://www.wikidata.org/entity/Q41207847

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Multicenter randomized phase I ...... eekly XELOX (The ORION Study).

@en

type

Item

label

Multicenter randomized phase I ...... eekly XELOX (The ORION Study).

@en

prefLabel

Multicenter randomized phase I ...... eekly XELOX (The ORION Study).

@en

P1476

Multicenter randomized phase I ...... eekly XELOX (The ORION Study).

@en

P2093

Akitomo Fujii

http://www.w3.org/2001/XMLSchema#string

Chihiro Tanaka

http://www.w3.org/2001/XMLSchema#string

Chu Matsuda

http://www.w3.org/2001/XMLSchema#string

Hideyuki Mishima

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Bando

http://www.w3.org/2001/XMLSchema#string

Keiichiro Ishibashi

http://www.w3.org/2001/XMLSchema#string

Michitaka Honda

http://www.w3.org/2001/XMLSchema#string

Michiya Kobayashi

http://www.w3.org/2001/XMLSchema#string

Mitsuru Oshiro

http://www.w3.org/2001/XMLSchema#string

Mutsumi Fukunaga

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancer.

Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer.

Modified CAPOX (capecitabine plus oxaliplatin) regimen every two weeks as second-line treatment in patients with advanced colorectal cancer previously treated with irinotecan-based frontline therapy: a multicenter phase II study.

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results.

A randomized, phase II trial of standard triweekly compared with dose-dense biweekly capecitabine plus oxaliplatin plus bevacizumab as first-line treatment for metastatic colorectal cancer: XELOX-A-DVS (dense versus standard)

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double‑blind, placebo‑controlled trial of goshajinkigan to prevent oxaliplatin‑induced neuropathy.

Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).

P2888

s10147-015-0911-7

P304

566-572

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10147-015-0911-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Koji Oba

P577

2015-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282944613

http://www.w3.org/2001/XMLSchema#string

P6179

1011995240

http://www.w3.org/2001/XMLSchema#string

P698

26475356

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

phase II clinical trial

multicenter trial

Multicenter randomized phase II clinical trial of oxaliplatin reintroduction as a third- or later-line therapy for metastatic colorectal cancer-biweekly versus standard triweekly XELOX (The ORION Study).

about

P2860

P2860

Multicenter randomized phase II clinical trial of oxaliplatin reintroduction as a third- or later-line therapy for metastatic colorectal cancer-biweekly versus standard triweekly XELOX (The ORION Study).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P921